Bladder papillary urothelial carcinoma
MONDO:0004056An invasive or non-invasive papillary transitional cell carcinoma of the urinary bladder. It is classified as low - or high-grade. -- 2003
Also known as: bladder papillary urothelial carcinoma, urinary bladder papillary transitional cell carcinoma, urothelial papillary carcinoma of the bladder, bladder urothelial papillary carcinoma
2780 clinical trials for this condition and its sub-types, 11 tagged with Bladder papillary urothelial carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for bladder cancer patients avoiding bladder removal
Disease control OngoingThis study tests two experimental treatments—TAR-200 (a drug placed inside the bladder) and cetrelimab (an immunotherapy injection)—alone or together, in people with high-risk bladder cancer that came back after BCG therapy. Participants are those who cannot or choose not to have…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Virus therapy shows promise for tough bladder cancer cases
Disease control OngoingThis phase 3 trial is testing a new treatment called cretostimogene grenadenorepvec for people with a type of bladder cancer (non-muscle invasive) that did not improve after standard BCG therapy. The treatment uses a modified virus to target and destroy cancer cells. About 190 pa…
Phase 3 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC